• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Revolution Medicines, Inc. - Common Stock (NQ:RVMD)

    162.99 +5.22 (+3.31%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,699,568
    Open 160.66
    Bid (Size) 161.00 (1,000)
    Ask (Size) 162.95 (800)
    Prev. Close 157.77
    Today's Range 158.40 - 164.78
    52wk Range 34.00 - 166.50
    Shares Outstanding 106,313,250
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Can Revolution Medicines Be a Game-Changer Stock? ↗
    This company's potential pancreatic cancer blockbuster could be a watershed moment. 
    Via The Motley Fool
    News headline image
    Revolution Medicines Is Up 97% This Year: Here Are the Bull and Bear Cases for This Soaring Biotech Stock. ↗
    Can the drugmaker justify its valuation? 
    Via The Motley Fool

    Performance

    YTD
    +106.3%
    +106.3%
    1 Month
    +12.9%
    +12.9%
    3 Month
    +66.1%
    +66.1%
    6 Month
    +112.4%
    +112.4%
    1 Year
    +316.4%
    +316.4%

    More News

    Read More
    Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
    Via Investor Brand Network
    Revolution Medicines Inc (NASDAQ:RVMD) Q1 2026 Loss Widens Amid Clinical Promise ↗
    Via Chartmill
    NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Drug Delivery and Platform-Based Biotech Innovation
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
    From BioMedWire
    Via GlobeNewswire
    News headline image
    Biotech Fund Sells $44.5 Million Erasca Stake After Massive 700% Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗
    Via The Motley Fool
    News headline image
    This Nuclear Tech Stock Grew Revenue 27%, But a Fund Still Slashed Its Stake ↗
    Via The Motley Fool
    Topics Energy Regulatory Compliance
    News headline image
    This Retail Stock Is Down 10% in a Year Despite Record Revenue. A Fund Just Cut Its Stake ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Trade School Stock Is Up 135%. Here’s Why a Fund Still Bought 459,000 Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Callaway Stock Has Soared 150%. Here’s Why One Fund Still Bought 1.1 Million Shares ↗
    Via The Motley Fool
    News headline image
    Revolution (RVMD) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Revolution Medicines Has a Market Cap of $29 Billion and Generates No Revenue. Here's Why Its Valuation May Not Be as Ridiculous as It Seems ↗
    Via The Motley Fool
    News headline image
    Revolution Medicines (RVMD): The New Titan of the RAS Pathway (2026 Research Feature)
    Via Finterra
    Topics Initial Public Offering
    News headline image
    The RAS Revolution: A Deep Dive into Revolution Medicines’ Path to Dominance (2026 Report)
    Via Finterra
    Topics Economy Initial Public Offering Intellectual Property
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Which stocks are moving before the opening bell on Monday? ↗
    Via Chartmill
    News headline image
    Daraxonrasib Demonstrates Unprecedented Overall Survival Benefit in Pivotal Phase 3 RASolute 302 Clinical Trial in Patients with Metastatic Pancreatic Cancer
    From Revolution Medicines, Inc.
    Via GlobeNewswire
    News headline image
    Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential? ↗
    Via The Motley Fool
    News headline image
    This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is Revolution Medicines, Inc. - Common Stock publicly traded?
    Yes, Revolution Medicines, Inc. - Common Stock is publicly traded.
    What exchange does Revolution Medicines, Inc. - Common Stock trade on?
    Revolution Medicines, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Revolution Medicines, Inc. - Common Stock?
    The ticker symbol for Revolution Medicines, Inc. - Common Stock is RVMD on the Nasdaq Stock Market
    What is the current price of Revolution Medicines, Inc. - Common Stock?
    The current price of Revolution Medicines, Inc. - Common Stock is 162.99
    When was Revolution Medicines, Inc. - Common Stock last traded?
    The last trade of Revolution Medicines, Inc. - Common Stock was at 06/18/26 04:00 PM ET
    What is the market capitalization of Revolution Medicines, Inc. - Common Stock?
    The market capitalization of Revolution Medicines, Inc. - Common Stock is 17.33B
    How many shares of Revolution Medicines, Inc. - Common Stock are outstanding?
    Revolution Medicines, Inc. - Common Stock has 17B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.